BB
Bone Biologics Corporation
BBLGW · NASDAQ
$4.00 -25.93% (-$1.40)
1M -41.49%
Market Cap $8.15M
P/E Ratio -
Div. Yield -
ROE 57.85%
Bulios Fair Price
$2.11
47.3% downside
Current Price
$4
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BBLGW is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
86 /100
Cheap P/B 2.08x
P/E N/A
EV/EBITDA N/A
Growth
8 /100
Declining Book val. growth 3.30%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 78.01%
ROE 57.85%
ROA 65.16%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 8.67x
Int. coverage N/A
Stability
48 /100
Moderate Beta 0.53x
EPS volatility 47.56%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BBLGW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jeffrey Frelick
Employees
2
Headquarters
Burlington
Upcoming events
02 DEC
Earnings
Upcoming earnings report